
Ceftivolk-S 375mg Injection
Marketer
Medivolks Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftivolk-S 375mg Injection
Ceftivolk-S 375mg Injection, a combined medication, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be solely under a healthcare provider's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation can compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, breathing difficulties). Inform your physician about all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is uncommon, avoid driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and sufficient hydration promote faster recovery. Your doctor might order tests to monitor the medication's impact.
Uses of Ceftivolk-S 375mg Injection
Infections caused by bacteria
Major Benefits of Ceftivolk-S 375mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ceftivolk-S 375mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftivolk-S 375mg Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strongly discouraged.
How Ceftivolk-S 375mg Injection works:
Ceftriaxone and sulbactam, combined as Ceftivolk-S 375mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, inhibiting their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements this by countering bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Ceftivolk-S 375mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftivolk-S 375mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nonetheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The use of Ceftivolk-S 375mg Injection while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Ceftivolk-S 375mg can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Ceftivolk-S 375mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Ceftivolk-S 375mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Ceftivolk-S 375mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftivolk-S 375mg Injection :
Should you inadvertently omit a dose of Ceftivolk-S 375mg Injection, seek your physician's advice.
Facts to Know About Ceftivolk-S 375mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
